Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-07-16

FDA Approved: TIMOPTIC-XE — Supplemental Application (Bausch & Lomb Incorporated)

View source ↗

Summary

The FDA approved a supplemental application for TIMOPTIC-XE (timolol maleate) from Bausch & Lomb Incorporated, authorizing changes to the product's existing app…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TIMOPTIC-XE (TIMOLOL MALEATE)

Snippet

SUPPL AP for TIMOPTIC-XE (TIMOLOL MALEATE)